Cancer Drug Delivery and Nanotechnology I

Track Chair(s)

• 

  Jan Lammerding, PhD (he/him/his)

  Professor
  Cornell University
  Ithaca, New York, United States
• JW

  Jessica Winter

  Professor
  The Ohio State University, United States

Moderator(s)

• DH

  Daniel Hayes

  Department Head of Biomedical Engineering
  Pennsylvania State University, United States
• 

  Anandi Krishnan, PhD (she/her/hers)

  Stanford University - School of Medicine
  Palo Alto, California, United States

Presentations:

• 8:00 AM – 8:15 AM PDT

  A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
  

  Presenting Author: Yafei Su (she/her/hers) – University at Buffalo, The State University of New York

  Co-Author: Tatiana Shaurova – Roswell Park Comprehensive Cancer Center

  Co-Author: Lingyue Yan – University at Buffalo, The State University of New York

  Co-Author: Laurie J Rich – FUJIFILM VisualSonics, Inc

  Co-Author: Vui King Vincent-Chong – Roswell Park Comprehensive Cancer Center

  Co-Author: Hannah Calkins – Roswell Park Comprehensive Cancer Center

  Co-Author: Saraswati Pokharel – Roswell Park Comprehensive Cancer Center

  Co-Author: Martin Petkovich – Queens University

  Co-Author: Mukund Seshadri – Roswell Park Comprehensive Cancer Center

  Primary Investigator: Yun Wu, PhD – University at Buffalo, The State University of New York

  Last Author: Pamela A Hershberger – Roswell Park Comprehensive Cancer Center
• 8:15 AM – 8:30 AM PDT

  Applying activity-based nanotechnologies towards lung cancer interception
  

  Presenting Author: Cathy Wang – Massachusetts Institute of Technology

  Co-Author: Qian Zhong – MIT

  Co-Author: Shih-Ting Wang, PhD (she/her/hers) – Massachusetts Institute of Technology

  Co-Author: Carmen Martin Alonso (she/her/hers) – Massachussetts Institute of Technology / Harvard University

  Co-Author: Tiziana Parisi – MIT

  Co-Author: Sahil Patel – Massachusetts Institute of Technology

  Co-Author: Tyler Jacks – MIT

  Primary Investigator: Sangeeta Bhatia – Massachusetts Institute of Technology
• 8:30 AM – 8:45 AM PDT

  Microdissected “cuboids” as a model system for cancer drug testing
  

  Presenting Author: Lisa Horowitz, MD PhD – University of Washington

  Co-Author: Tran N. H Nguyen, PhD (she/her/hers) – Department of Bioengineering/University of Washington

  Co-Author: Ethan Lockhart (he/him/his) – University of Washington

  Co-Author: Ricard Rodriguez – University of Washington

  Co-Author: Chuan Bian Lim – Human Biology Division, Fred Hutchinson Cancer Research Center

  Co-Author: Heidi Kenerson – University of Washington

  Co-Author: Judit Villen – University of Washington

  Co-Author: Raymond S Yeung, MD – University of Washington

  Co-Author: Taranjit Gujral – Human Biology Division, Fred Hutchinson Cancer Research Center

  Last Author: Albert Folch (he/him/his) – University of Washington
• 8:45 AM – 9:00 AM PDT

  Stroma Affects the Intratumoral Transport of Bacteria-Based Cancer Therapy
  

  Co-Author: Ying Zhan – Virginia Tech

  Co-Author: Brian Burkel – University of Wisconsin

  Co-Author: Suzanne Ponik – University of Wisconsin

  Presenting Author: Bahareh Behkam, PhD (she/her/hers) – Virginia Tech
• 9:00 AM – 9:30 AM PDT

  Engineering the gut microbiome and immune system to improve cancer immunotherapy
  

  Presenting Author: James Moon, PhD – University of Michigan, Ann Arbor